I know Donna and Paul didn’t call the results “Stellar” but they did call them “particularly unique, strong signals for disease modification, remarkable findings - particularly at 6months, no previous study out there that has shown improvement in cartilage like PAR has, world first, ground breakin”
”no other drug where a subject is dosed and 6months later, the effect of the drug is still significant. Long term, durable effect from the symptoms of OA”
yum
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-318
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $73.55M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $216.0K | 1.057M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 143324 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 44935 | 3 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |